Engineers Gate Manager LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$209,312
-79.9%
5,868
-85.8%
0.01%
-71.1%
Q4 2020$1,041,000
+371.0%
41,357
+289.7%
0.04%
+350.0%
Q3 2020$221,000
-54.4%
10,612
-48.0%
0.01%
-60.0%
Q2 2020$485,000
-87.4%
20,427
-87.4%
0.02%
-85.2%
Q4 2019$3,846,000
+176.3%
162,156
+308.1%
0.17%
+101.2%
Q1 2019$1,392,000
-7.3%
39,731
-12.1%
0.08%
-30.0%
Q4 2018$1,501,000
-54.3%
45,197
-17.7%
0.12%
-53.1%
Q2 2018$3,286,000
+5.6%
54,903
-19.2%
0.26%
+23.7%
Q1 2018$3,111,000
+78.4%
67,922
+55.2%
0.21%
+72.5%
Q4 2017$1,744,000
-12.3%
43,767
-11.9%
0.12%
-28.1%
Q3 2017$1,988,000
-36.9%
49,690
-32.0%
0.17%
-41.2%
Q2 2017$3,151,000
+132.7%
73,110
+69.0%
0.28%
+111.9%
Q1 2017$1,354,000
+1.7%
43,272
-19.6%
0.13%
-3.6%
Q3 2016$1,332,000
+28.3%
53,849
+5.7%
0.14%
+87.8%
Q2 2016$1,038,000
+396.7%
50,965
+272.6%
0.07%
+362.5%
Q1 2016$209,000
-85.0%
13,680
-86.3%
0.02%
-86.6%
Q3 2015$1,396,000
+4.1%
99,520
+26.1%
0.12%
-9.2%
Q2 2015$1,341,000
+707.8%
78,951
+474.3%
0.13%
+495.5%
Q1 2015$166,00013,7480.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders